Loading organizations...
Loading organizations...
Developer of novel pharmaceuticals for neurogenic inflammation treatment.
Nocion Therapeutics has raised $112.0M across 3 funding rounds.
Nocion Therapeutics has raised $112.0M in total across 3 funding rounds.
Nocion Therapeutics has raised $112.0M in total across 3 funding rounds.
Nocion Therapeutics's investors include Pini Orbach, Monograph Capital, Canaan Partners, F-Prime Capital, Lumira Ventures, Mass General Brigham Ventures, Mission BioCapital, Morningside, Osage University Partners, Freddie Dear, Julie Grant, Partners Innovation Fund.
Nocion Therapeutics has raised $112.0M across 3 funding rounds. Most recently, it raised $23.0M Series B Extension in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 7, 2026 | $23.0M Series B Extension | Pini Orbach, Monograph Capital | Canaan Partners, F-Prime Capital, Lumira Ventures, Mass General Brigham Ventures, Mission BioCapital, Morningside, Osage University Partners |
| Mar 4, 2024 | $62.0M Series B | Pini Orbach, Freddie Dear | Julie Grant, Canaan Partners, F-Prime Capital, Mass General Brigham Ventures, Mission BioCapital, Osage University Partners |
| Apr 18, 2019 | $27.0M Series A | Canaan Partners, F-Prime Capital | Mission BioCapital, Partners Innovation Fund |